10603-53-9 Usage
Uses
Used in Pharmaceutical Industry:
PYRROLIDINE-3-CARBONITRILE is used as a key building block for the synthesis of various drugs and pharmaceutical intermediates due to its unique five-membered ring structure and ability to contribute to the development of pyrrolidine-based compounds with significant biological activities.
Used in Organic Synthesis:
PYRROLIDINE-3-CARBONITRILE is utilized as a versatile component in organic synthesis, enabling the creation of a wide array of chemical compounds that are valuable in various applications across different industries.
Used in Agrochemical Development:
In the agrochemical sector, PYRROLIDINE-3-CARBONITRILE is employed as a fundamental component in the synthesis of compounds that have applications in crop protection and other agricultural chemical products, leveraging its reactivity and structural properties to enhance product efficacy.
Used in Fine Chemicals Production:
PYRROLIDINE-3-CARBONITRILE is used as a critical intermediate in the production of fine chemicals, where its unique structural attributes and synthetic versatility are harnessed to create high-value specialty chemicals for diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 10603-53-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,6,0 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 10603-53:
(7*1)+(6*0)+(5*6)+(4*0)+(3*3)+(2*5)+(1*3)=59
59 % 10 = 9
So 10603-53-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H8N2/c6-3-5-1-2-7-4-5/h5,7H,1-2,4H2
10603-53-9Relevant academic research and scientific papers
Glutaminase inhibitors as well as compositions and applications thereof
-
Paragraph 0385; 0395; 0396; 0397, (2018/01/09)
The invention provides a series of heterocyclic compounds expressed in a formula I. The compound comprises glutaminase inhibition activity, and can be used for treating diseases and symptoms related to dysfunction of glutaminase or raising activity of glutaminase.
PYRIDINE AND PYRIMIDINE BASED COMPOUNDS AS WNT SIGNALING PATHWAY INHIBITORS FOR THE TREATMENT OF CANCER
-
Page/Page column 36, (2010/04/28)
The present invention relates to pyridine and pyrimidine based compounds, pharmaceutical compositions comprising these compounds and their potential use as therapeutic agents for the treatment and / or prevention of cancer.
